Dr. Andrew M Brunner, MD
Claim this profileMassachusetts General Hospital Cancer Center
Studies Myelodysplastic Syndrome
Studies Myelodysplastic syndrome
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Andrew M Brunner, MD is currently running
MBG453
for Preleukemia
This research study is assessing the efficacy of MBG-453, a humanized monoclonal antibody, in treating myelodysplastic syndromes (MDS). The name of the study drug involved in this study is MBG453.
Recruiting1 award Phase 2
AZD6738
for Myelodysplastic Syndrome
This research study is studying a research drug called AZD6738 as a possible treatment for Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia .
Recruiting1 award Phase 110 criteria
More about Andrew M Brunner, MD
Clinical Trial Related3 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andrew M Brunner, MD has experience with
- AZD6738
- MBG453
Breakdown of trials Andrew M Brunner, MD has run
Myelodysplastic Syndrome
Myelodysplastic syndrome
T-Lymphoblastic Leukemia/Lymphoma
Postprandial Fullness Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew M Brunner, MD specialize in?
Andrew M Brunner, MD focuses on Myelodysplastic Syndrome and Myelodysplastic syndrome. In particular, much of their work with Myelodysplastic Syndrome has involved treating patients, or patients who are undergoing treatment.
Is Andrew M Brunner, MD currently recruiting for clinical trials?
Yes, Andrew M Brunner, MD is currently recruiting for 2 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Andrew M Brunner, MD has studied deeply?
Yes, Andrew M Brunner, MD has studied treatments such as AZD6738, MBG453.
What is the best way to schedule an appointment with Andrew M Brunner, MD?
Apply for one of the trials that Andrew M Brunner, MD is conducting.
What is the office address of Andrew M Brunner, MD?
The office of Andrew M Brunner, MD is located at: Massachusetts General Hospital Cancer Center, Boston, Massachusetts 02215 United States. This is the address for their practice at the Massachusetts General Hospital Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.